Molecular Human Reproduction · 2005 · 56 citations · 19 references
MedicineEndocrinologyGeneticsHuman GeneticsReproductive EndocrinologyReproductive GeneticsEndocrine Developmental GeneticsGenotype-phenotype CorrelationMale Reproductive EndocrinologyPolycystic Ovary SyndromePubertyAdolescent Polycystic Ovary SyndromeGenomic Dna AnalysisGenotype Data AnalysisHormonal Gene VariantsMedian AgeMenarche TimingSex Hormone-binding Globulin
The age of menarche may be subject to hereditary influences but the specific determinants are unknown. Our aim was to investigate the possible association of a functional (TAAAA)n polymorphism in the promoter of the sex hormone-binding globulin (SHBG) gene with the timing of menarche. This polymorphism has been associated with polycystic ovary syndrome (PCOS) and is considered to contribute to SHBG levels. We studied 130 healthy normal-weight adolescent females from a closed community in North-Western Greece. Information on menarche was obtained through interviews. The BMI was recorded. Genomic DNA was isolated from peripheral blood leukocytes for genotyping the TAAAA repeat region. We subdivided our subjects into two groups based on median age of menarche: those with menarche <13 years and those with menarche > or =13 years. Genotype analysis revealed six (TAAAA)n alleles containing 5-10 TAAAA repeats. The distribution of alleles was different in the two groups. Girls with late menarche had more frequently longer TAAAA alleles (>8 repeats), while girls with early menarche had shorter alleles at a greater frequency (P=0.048). The major contribution to early menarche was by the 6 TAAAA repeat allele. Furthermore, carriers of the longer allele genotypes had later menarche (13.24+/-1.15 years) than those with shorter allele genotypes (12.67+/-1.15, P=0.018). These findings provide evidence for a genetic contribution of SHBG gene to the age of menarche.
19
Common genetic influences on BMI and age at menarche.
Jaakko Kaprio, Arja Rimpelä, Torsten Winter et al. · PubMed · 1995 · 311 citations
A polymorphism in the CYP17 gene increases the risk of breast cancer.
Heather Spencer Feigelson, Gerhard A. Coetzee, Laurence N. Kolonel et al. · PubMed · 1997 · 248 citations · Full text
The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer.
C. A. Haiman, Susan E. Hankinson, Donna Spiegelman et al. · PubMed · 1999 · 223 citations
Medicine, Endocrinology, Genetics +16
Nectaria Xita, Agathocles Tsatsoulis, A. Chatzikyriakidou et al. · The Journal of Clinical Endocrinology & Metabolism · 2003 · 126 citations · Full text
Medicine, Endocrinology, Genetics +10